Cargando…

Evidence-based policymaking is not like evidence-based medicine, so how far should you go to bridge the divide between evidence and policy?

There is extensive health and public health literature on the ‘evidence-policy gap’, exploring the frustrating experiences of scientists trying to secure a response to the problems and solutions they raise and identifying the need for better evidence to reduce policymaker uncertainty. We offer a new...

Descripción completa

Detalles Bibliográficos
Autores principales: Cairney, Paul, Oliver, Kathryn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407004/
https://www.ncbi.nlm.nih.gov/pubmed/28446185
http://dx.doi.org/10.1186/s12961-017-0192-x
_version_ 1783232078638219264
author Cairney, Paul
Oliver, Kathryn
author_facet Cairney, Paul
Oliver, Kathryn
author_sort Cairney, Paul
collection PubMed
description There is extensive health and public health literature on the ‘evidence-policy gap’, exploring the frustrating experiences of scientists trying to secure a response to the problems and solutions they raise and identifying the need for better evidence to reduce policymaker uncertainty. We offer a new perspective by using policy theory to propose research with greater impact, identifying the need to use persuasion to reduce ambiguity, and to adapt to multi-level policymaking systems. We identify insights from secondary data, namely systematic reviews, critical analysis and policy theories relevant to evidence-based policymaking. The studies are drawn primarily from countries such as the United States, United Kingdom, Canada, Australia and New Zealand. We combine empirical and normative elements to identify the ways in which scientists can, do and could influence policy. We identify two important dilemmas, for scientists and researchers, that arise from our initial advice. First, effective actors combine evidence with manipulative emotional appeals to influence the policy agenda – should scientists do the same, or would the reputational costs outweigh the policy benefits? Second, when adapting to multi-level policymaking, should scientists prioritise ‘evidence-based’ policymaking above other factors? The latter includes governance principles such the ‘co-production’ of policy between local public bodies, interest groups and service users. This process may be based primarily on values and involve actors with no commitment to a hierarchy of evidence. We conclude that successful engagement in ‘evidence-based policymaking’ requires pragmatism, combining scientific evidence with governance principles, and persuasion to translate complex evidence into simple stories. To maximise the use of scientific evidence in health and public health policy, researchers should recognise the tendency of policymakers to base judgements on their beliefs, and shortcuts based on their emotions and familiarity with information; learn ‘where the action is’, and be prepared to engage in long-term strategies to be able to influence policy; and, in both cases, decide how far you are willing to go to persuade policymakers to act and secure a hierarchy of evidence underpinning policy. These are value-driven and political, not just ‘evidence-based’, choices.
format Online
Article
Text
id pubmed-5407004
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54070042017-05-02 Evidence-based policymaking is not like evidence-based medicine, so how far should you go to bridge the divide between evidence and policy? Cairney, Paul Oliver, Kathryn Health Res Policy Syst Opinion There is extensive health and public health literature on the ‘evidence-policy gap’, exploring the frustrating experiences of scientists trying to secure a response to the problems and solutions they raise and identifying the need for better evidence to reduce policymaker uncertainty. We offer a new perspective by using policy theory to propose research with greater impact, identifying the need to use persuasion to reduce ambiguity, and to adapt to multi-level policymaking systems. We identify insights from secondary data, namely systematic reviews, critical analysis and policy theories relevant to evidence-based policymaking. The studies are drawn primarily from countries such as the United States, United Kingdom, Canada, Australia and New Zealand. We combine empirical and normative elements to identify the ways in which scientists can, do and could influence policy. We identify two important dilemmas, for scientists and researchers, that arise from our initial advice. First, effective actors combine evidence with manipulative emotional appeals to influence the policy agenda – should scientists do the same, or would the reputational costs outweigh the policy benefits? Second, when adapting to multi-level policymaking, should scientists prioritise ‘evidence-based’ policymaking above other factors? The latter includes governance principles such the ‘co-production’ of policy between local public bodies, interest groups and service users. This process may be based primarily on values and involve actors with no commitment to a hierarchy of evidence. We conclude that successful engagement in ‘evidence-based policymaking’ requires pragmatism, combining scientific evidence with governance principles, and persuasion to translate complex evidence into simple stories. To maximise the use of scientific evidence in health and public health policy, researchers should recognise the tendency of policymakers to base judgements on their beliefs, and shortcuts based on their emotions and familiarity with information; learn ‘where the action is’, and be prepared to engage in long-term strategies to be able to influence policy; and, in both cases, decide how far you are willing to go to persuade policymakers to act and secure a hierarchy of evidence underpinning policy. These are value-driven and political, not just ‘evidence-based’, choices. BioMed Central 2017-04-26 /pmc/articles/PMC5407004/ /pubmed/28446185 http://dx.doi.org/10.1186/s12961-017-0192-x Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Opinion
Cairney, Paul
Oliver, Kathryn
Evidence-based policymaking is not like evidence-based medicine, so how far should you go to bridge the divide between evidence and policy?
title Evidence-based policymaking is not like evidence-based medicine, so how far should you go to bridge the divide between evidence and policy?
title_full Evidence-based policymaking is not like evidence-based medicine, so how far should you go to bridge the divide between evidence and policy?
title_fullStr Evidence-based policymaking is not like evidence-based medicine, so how far should you go to bridge the divide between evidence and policy?
title_full_unstemmed Evidence-based policymaking is not like evidence-based medicine, so how far should you go to bridge the divide between evidence and policy?
title_short Evidence-based policymaking is not like evidence-based medicine, so how far should you go to bridge the divide between evidence and policy?
title_sort evidence-based policymaking is not like evidence-based medicine, so how far should you go to bridge the divide between evidence and policy?
topic Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407004/
https://www.ncbi.nlm.nih.gov/pubmed/28446185
http://dx.doi.org/10.1186/s12961-017-0192-x
work_keys_str_mv AT cairneypaul evidencebasedpolicymakingisnotlikeevidencebasedmedicinesohowfarshouldyougotobridgethedividebetweenevidenceandpolicy
AT oliverkathryn evidencebasedpolicymakingisnotlikeevidencebasedmedicinesohowfarshouldyougotobridgethedividebetweenevidenceandpolicy